2. Academic Validation
  3. A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy

A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy

  • Nat Commun. 2026 Mar 31. doi: 10.1038/s41467-026-71363-6.
Qianwen Mu # 1 2 3,  Haolan Deng # 1 2,  Shuo Li # 1,  Xiaoyu An 1 2,  Xuan Liu 2,  Yue Xi 1,  Hao Liang 1,  Di Sun 1,  Xiaojun Wang 1,  Xue Liu 2,  Gang Liu 4 5,  Chao Liu 6 7 8
Affiliations

Affiliations

  • 1 Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • 2 Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, China.
  • 3 State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China.
  • 4 Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, China. [email protected].
  • 5 State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China. [email protected].
  • 6 Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China. [email protected].
  • 7 Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, China. [email protected].
  • 8 Shenzhen Research Institute of Xiamen University, Shenzhen, China. [email protected].
  • # Contributed equally.
PMID: 41917023 DOI: 10.1038/s41467-026-71363-6
Abstract

The epigenetic silencing or remarkably diminished expression of STING in Cancer cells, along with the structural and functional impairment of the endoplasmic reticulum (ER) and Golgi apparatus, represents a unique mechanism of tumor immune escape and poses an important challenge for STING-targeted therapies. Here, we develop a cell membrane-derived nanodisc system (ND-cGAMP-HP; HP, heparin), which is capable of presenting activated STING proteins in their native form by means of cell membrane-directed display and biological self-assembly techniques. It can directly introduce activated STING protein to tumor cells and circumvent the translocation process between the ER and Golgi apparatus, selectively activating the IFN-I signaling pathway without initiating the inflammation-related pathway NF-κB. ND-cGAMP-HP triggers potent cellular immune responses and remodels the tumor immune microenvironment. Moreover, it augments immune memory by promoting the differentiation of TCF1+ stem cell-like T cells. We thus manifest a strategy based on STING therapy that does not depend on the ER and Golgi apparatus pathways to activate the IFN-I pathway, for Cancer Immunotherapy.

Figures
Products